N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS
The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use. La presente invención se refiere a formas novedosas estables de...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | CARRA Ernest A WARR Matthew Robert MORRISON Henry WHITNEY James Andrew STEFANIDIS Dimitrios XIN Yan WANG Fang BROWN Brandon H HEMENWAY Jeffrey N SHI Bing REYNOLDS Troy |
description | The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2022015558A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2022015558A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2022015558A3</originalsourceid><addsrcrecordid>eNrjZIj209VwjnT08_d1DfGI9NHUNdHVMNLVMNH19Q8K8PD38fTzD_Bw9Yv0cfQFMjUDIoM8fT1dPP2A6oCqnVz9FKKAMi6uCh6RLkH-zh4-_kEgXrCjT0gwDwNrWmJOcSovlOZmUHJzDXH20E0tyI9PLS5ITE7NSy2J940wMjAyMjA0NTW1cDQmShEAsYQySg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><source>esp@cenet</source><creator>CARRA Ernest A ; WARR Matthew Robert ; MORRISON Henry ; WHITNEY James Andrew ; STEFANIDIS Dimitrios ; XIN Yan ; WANG Fang ; BROWN Brandon H ; HEMENWAY Jeffrey N ; SHI Bing ; REYNOLDS Troy</creator><creatorcontrib>CARRA Ernest A ; WARR Matthew Robert ; MORRISON Henry ; WHITNEY James Andrew ; STEFANIDIS Dimitrios ; XIN Yan ; WANG Fang ; BROWN Brandon H ; HEMENWAY Jeffrey N ; SHI Bing ; REYNOLDS Troy</creatorcontrib><description>The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230130&DB=EPODOC&CC=MX&NR=2022015558A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230130&DB=EPODOC&CC=MX&NR=2022015558A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CARRA Ernest A</creatorcontrib><creatorcontrib>WARR Matthew Robert</creatorcontrib><creatorcontrib>MORRISON Henry</creatorcontrib><creatorcontrib>WHITNEY James Andrew</creatorcontrib><creatorcontrib>STEFANIDIS Dimitrios</creatorcontrib><creatorcontrib>XIN Yan</creatorcontrib><creatorcontrib>WANG Fang</creatorcontrib><creatorcontrib>BROWN Brandon H</creatorcontrib><creatorcontrib>HEMENWAY Jeffrey N</creatorcontrib><creatorcontrib>SHI Bing</creatorcontrib><creatorcontrib>REYNOLDS Troy</creatorcontrib><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><description>The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIj209VwjnT08_d1DfGI9NHUNdHVMNLVMNH19Q8K8PD38fTzD_Bw9Yv0cfQFMjUDIoM8fT1dPP2A6oCqnVz9FKKAMi6uCh6RLkH-zh4-_kEgXrCjT0gwDwNrWmJOcSovlOZmUHJzDXH20E0tyI9PLS5ITE7NSy2J940wMjAyMjA0NTW1cDQmShEAsYQySg</recordid><startdate>20230130</startdate><enddate>20230130</enddate><creator>CARRA Ernest A</creator><creator>WARR Matthew Robert</creator><creator>MORRISON Henry</creator><creator>WHITNEY James Andrew</creator><creator>STEFANIDIS Dimitrios</creator><creator>XIN Yan</creator><creator>WANG Fang</creator><creator>BROWN Brandon H</creator><creator>HEMENWAY Jeffrey N</creator><creator>SHI Bing</creator><creator>REYNOLDS Troy</creator><scope>EVB</scope></search><sort><creationdate>20230130</creationdate><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><author>CARRA Ernest A ; WARR Matthew Robert ; MORRISON Henry ; WHITNEY James Andrew ; STEFANIDIS Dimitrios ; XIN Yan ; WANG Fang ; BROWN Brandon H ; HEMENWAY Jeffrey N ; SHI Bing ; REYNOLDS Troy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2022015558A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CARRA Ernest A</creatorcontrib><creatorcontrib>WARR Matthew Robert</creatorcontrib><creatorcontrib>MORRISON Henry</creatorcontrib><creatorcontrib>WHITNEY James Andrew</creatorcontrib><creatorcontrib>STEFANIDIS Dimitrios</creatorcontrib><creatorcontrib>XIN Yan</creatorcontrib><creatorcontrib>WANG Fang</creatorcontrib><creatorcontrib>BROWN Brandon H</creatorcontrib><creatorcontrib>HEMENWAY Jeffrey N</creatorcontrib><creatorcontrib>SHI Bing</creatorcontrib><creatorcontrib>REYNOLDS Troy</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CARRA Ernest A</au><au>WARR Matthew Robert</au><au>MORRISON Henry</au><au>WHITNEY James Andrew</au><au>STEFANIDIS Dimitrios</au><au>XIN Yan</au><au>WANG Fang</au><au>BROWN Brandon H</au><au>HEMENWAY Jeffrey N</au><au>SHI Bing</au><au>REYNOLDS Troy</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><date>2023-01-30</date><risdate>2023</risdate><abstract>The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_MX2022015558A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A44%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CARRA%20Ernest%20A&rft.date=2023-01-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2022015558A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |